What are the recommended anti-inflammatory medications for children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Anti-Inflammatory Medications for Children

For pain and inflammation in children, ibuprofen is the first-line NSAID choice for most conditions, while naproxen is preferred specifically for juvenile idiopathic arthritis (JIA) and chronic inflammatory conditions. 1, 2

Primary NSAID Recommendations

Ibuprofen

  • Ibuprofen is the drug of first choice for inflammatory pain in children aged ≥3 months, as it is the only NSAID approved for use in this age group 3, 4
  • Effective for multiple pain conditions including musculoskeletal pain, ear pain, acute otitis media, toothache, oral/pharyngeal inflammation, and postoperative pain 4
  • Has the lowest gastrointestinal toxicity among NSAIDs with a superior safety profile 5, 3
  • Provides mild-to-moderate analgesia with anti-inflammatory effects 5

Naproxen

  • Naproxen is the preferred NSAID over other selective COX-1 or COX-2 inhibitors for children with JIA due to its established efficacy and safety profile 1, 2
  • Recommended as adjuvant therapy for pain and inflammation in chronic inflammatory conditions 1, 2
  • Requires an adequate trial period of at least 8 weeks for conditions like JIA, given the time course to response of approximately 1 month 1, 2
  • If naproxen is contraindicated or unavailable, alternative NSAIDs (ibuprofen, indomethacin, meloxicam, tolmetin, etodolac, ketorolac, oxaprozin, or celecoxib) can be used based on FDA/EMA approval for pediatric use 1, 2

Paracetamol (Acetaminophen)

  • For fever and mild pain without significant inflammation, paracetamol should remain first-line therapy due to its superior tolerability profile compared to NSAIDs 5
  • Dosing: 10-15 mg/kg per dose every 4 hours, maximum 4 doses per day 6, 7
  • Paracetamol and ibuprofen show equivalent analgesic efficacy for short-term pain treatment in children, with no difference in safety 1
  • Paracetamol is preferred over ibuprofen when inflammation is not a primary component of the pain 5

Clinical Decision Algorithm

For Inflammatory Conditions:

  1. Chronic inflammatory disease (JIA): Start naproxen as adjuvant therapy 1, 2
  2. Acute inflammatory pain: Use ibuprofen as first-line 3, 4
  3. Postoperative pain: NSAIDs (ibuprofen, ketorolac, diclofenac) alone or as adjunct to regional anesthesia 5

For Non-Inflammatory Conditions:

  1. Fever with discomfort: Paracetamol first-line 5
  2. Mild-to-moderate pain without inflammation: Paracetamol first-line 7, 5

Critical Safety Considerations

Absolute Contraindications:

  • Never use ibuprofen in neonates 3
  • Avoid ibuprofen in children with dehydration, vomiting, or diarrhea due to risk of renal damage 3, 4
  • Do not use ibuprofen during varicella infection 3
  • Contraindicated in children with wheezing, persistent asthma, or NSAID sensitivity 3
  • Avoid aspirin in children due to Reye's syndrome risk, controversial efficacy, and toxicity concerns 1, 2, 5

Important Warnings:

  • Ibuprofen should not be used routinely as an antipyretic except in rare cases where inflammation accompanies fever 3
  • Ketorolac use after tonsillectomy remains controversial due to potential postoperative hemorrhage risk 5
  • NSAIDs should be used as adjunct therapy in JIA and should not delay introduction of disease-modifying antirheumatic drugs (DMARDs) 1, 2

Special Populations

Juvenile Idiopathic Arthritis:

  • NSAIDs are conditionally recommended as adjunct therapy 1
  • Intraarticular glucocorticoids are conditionally recommended as adjunct therapy 1
  • Triamcinolone hexacetonide is strongly recommended over triamcinolone acetonide for intraarticular injections 1
  • Methotrexate remains the cornerstone DMARD, with NSAIDs serving as adjunctive treatment 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Naproxen Use in Pediatric Pain Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pediatric dosing of acetaminophen.

Pediatric pharmacology (New York, N.Y.), 1983

Research

Paracetamol efficacy and safety in children: the first 40 years.

American journal of therapeutics, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.